PARDES BIOSCIENCES INC - COM (PRDS)

CUSIP: 69945Q105

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
39,101,270
Share change
+1,986,603
Total reported value
$282,283,105
Price per share
$7.22
Number of holders
57
Value change
-$20,289,253
Number of buys
33
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 69945Q105?
CUSIP 69945Q105 identifies PRDS - PARDES BIOSCIENCES INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PARDES BIOSCIENCES INC - COM (PRDS) as of Q1 2022

As of 31 Mar 2022, PARDES BIOSCIENCES INC - COM (PRDS) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,101,270 shares. The largest 10 holders included Foresite Capital Management V, LLC, RA CAPITAL MANAGEMENT, L.P., Foresite Capital Opportunity Management V, LLC, GOLDMAN SACHS GROUP INC, Frazier Life Sciences Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, Lynx1 Capital Management LP, PLATINUM INVESTMENT MANAGEMENT LTD, VANGUARD GROUP INC, and Arena Capital Advisors, LLC- CA. This page lists 57 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.